查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
罕見神經疾病治療市場:各類藥物，各疾病類型，各用途，各國，各地區:產業分析，市場規模，市場佔有率，2023-2030年預測
市場調查報告書
商品編碼
1320165

罕見神經疾病治療市場:各類藥物，各疾病類型，各用途，各國，各地區:產業分析，市場規模，市場佔有率，2023-2030年預測

Rare Neurological Disease Treatment Market with COVID-19 Impact Analysis, By Drug Class, By Disease Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 356 Pages | 商品交期: 2-3個工作天內

價格

報告要點

罕見神經系統疾病治療市場規模將於 2022 年達到 94.353 億美元，2023 年至 2030 年複合年增長率為 7.7%

罕見神經疾病治療市場 - 市場動態：

研發活動的增加預計將推動對罕見神經疾病治療的需求。

研究人員、醫療專業人員、製藥公司和患者權益團體之間的合作對於加速罕見神經系統疾病治療方法的發現至關重要。患者權益組織透過促進、支持和提高研究意識來改善患者治療結果和治療選擇。新一代定序、高通量篩選和基因編輯方法等技術的進步正在加速尋找和開發罕見神經系統疾病的可行治療方法。透過這些技術，研究人員能夠確定治療標靶、開發全新藥物並制定個人化治療策略。

基因組學和分子生物學的進步使人們更了解罕見神經系統疾病所涉及的生物遺傳學和分子生物學發展。這些資訊為精準醫學和標靶治療開啟了新的可能性。

罕見神經疾病治療市場 - 主要見解：

  • 據研究分析師分享的分析，全球罕見神經疾病治療市場在預測期內（2023-2030 年）預計將以每年約 7.7% 的複合年增長率增長。
  • 由於對動物健康和營養的日益關注，罕見神經疾病治療行業預計將大幅增長。
  • 按疾病類型劃分，阿茲海默症預計將在 2022 年佔最大的市場佔有率。
  • 從應用來看，到 2030 年，醫院藥局領域預計將佔主要市場佔有率。
  • 按藥物類別劃分，抗憂鬱藥物區隔市場將在 2022 年佔領先地位。
  • 依地區劃分，北美成為 2022 年最大的收入來源。

罕見神經系統疾病治療市場 - 區隔分析：

全球罕見神經疾病治療市場依據藥物類別、疾病類型、應用和區域進行區隔。

市場依藥物類別分為五大類：抗憂鬱藥、抗精神病藥、膽鹼酯?抑制劑、生物製劑等。抗憂鬱藥物區隔市場佔主導地位。用於治療疾病的抗憂鬱藥物需求的不斷增長推動了市場的成長。

市場依疾病類型分為四類：阿茲海默症、發作性睡病、硬化症等。阿茲海默症領域佔市場主導地位。阿茲海默症的盛行率不斷上升正在影響市場的成長。

市場依應用分為三類：醫院和診所、手術中心和其他。醫院藥房領域佔市場主導地位。醫院層級神經系統疾病治療數量的增加推動了這一領域的成長。

罕見神經疾病治療市場 - 地理洞察：

從地理來看，該市場遍佈北美、拉丁美洲、歐洲、亞太地區和中東非洲地區。這些地區根據其開展業務的國家進一步劃分。

罕見神經疾病治療市場 - 競爭格局：

神經系統疾病的盛行率不斷增加，影響著罕見的神經系統疾病治療市場。公司使用多種銷售管道來銷售其解決方案和產品，例如公司網站和產品類型。產品在多種因素上競爭，包括技術、產品開發和行銷。公司鞏固其影響力和增加市場佔有率的主要方法和策略包括新產品發布、研發支出、分銷網絡開發和併購。以下介紹一些最近的趨勢。

最近動態

2021年，Biogen開發了小分子治療性反義寡核?酸Spinraza（nusinersen）。

研究的主要特點

  • 本研究報告提供了罕見神經疾病治療市場的市場規模、複合年增長率、估計和預測（2023-2030 年），並以 2022 年為基準年。
  • 這份研究報告為客戶提供了有關罕見神經疾病治療市場的最新趨勢見解。
  • 該研究報告闡明了各個區隔市場/國家的潛在成長機會，並解釋了罕見神經疾病治療市場有吸引力的投資主張矩陣。
  • 總體報告確定了新的投資機會、現有公司面臨的挑戰以及維持罕見神經疾病治療市場的成長因素
  • 研究範圍詳細討論了罕見神經疾病治療市場規模、預測、複合年增長率以及 COVID-19 對市場動態的影響。本報告也詳細介紹了新冠疫情後罕見神經系統疾病治療市場的詳細見解。
  • 為了向本報告的使用者提供對罕見神經疾病治療市場的全面了解，本報告也對罕見神經疾病治療市場的競爭格局和主要創新者進行了分析。
  • 研究涵蓋成長前景映射分析，根據市場規模、成長率和吸引力對所有產業領域進行基準測試。
  • 本報告提供了主要市場參與者的詳細公司概況，以幫助了解在罕見神經疾病治療市場運營的公司的財務狀況和跨藥物類別的戰略舉措。Masu。
  • 此外，該報告還揭示了全球和區域市場主要參與者的重要收購和併購、聯盟和合資企業、新產品發布、研發以及區域擴張。
  • 《全球罕見神經疾病治療市場報告》主要針對該行業的各個利益相關者，例如供應商、投資者、新進業者、分銷商和財務分析師。

目錄

第1章 罕見神經疾病治療市場概要

  • 調查範圍

第2章 摘要整理

  • 市場明細
  • 競爭考察

第3章 罕見神經疾病治療主要的市場趨勢

  • 罕見神經疾病治療推動市場要素
  • 罕見神經疾病治療阻礙市場要素
  • 罕見神經疾病治療市場機會
  • 罕見神經疾病治療市場今後趨勢

第4章 罕見神經疾病治療產業的調查

  • PEST分析
  • 波特的五力分析
  • 成長預測的製圖
  • 法規結構的分析

第5章 罕見神經疾病治療市場:COVID-19影響分析

  • COVID-19前的影響分析
  • COVID-19後的影響分析

第6章 罕見神經疾病治療的市場形勢

  • 罕見神經疾病治療市場佔有率分析，2022年
  • 各主要製造商的明細資料
    • 現有企業的分析
    • 新興企業的分析

第7章 罕見神經疾病治療市場- 各類藥物

  • 概要
    • 各類藥物的市場區隔佔有率分析
    • 抗憂鬱症藥
    • 抗精神病藥
    • 膽鹼酯?抑制劑
    • 生技藥品
    • 其他

第8章 罕見神經疾病治療市場- 各疾病類型

  • 概要
    • 各疾病類型市場區隔佔有率分析
    • 阿茲海默症
    • 猝睡症
    • 硬化症
    • 其他

第9章 罕見神經疾病治療市場- 各用途

  • 概要
    • 各用途市場區隔佔有率分析
    • 醫院和診療所
    • 外科中心
    • 其他

第10章 罕見神經疾病治療市場-各地區

  • 簡介
  • 北美
    • 概要
    • 北美的罕見神經疾病治療的主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概要
    • 歐洲的罕見神經疾病治療的主要製造商
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 其他
  • 亞太地區(APAC)
    • 概要
    • 亞太地區的罕見神經疾病治療的主要製造商
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 其他
  • 南美
    • 概要
    • 南美的罕見神經疾病治療的主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲
    • 概要
    • 中東及非洲的罕見神經疾病治療的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第11章 主要供應商分析- 罕見神經疾病治療產業

  • 競爭儀表板
  • 企業簡介
    • Biogen Inc.
    • Genzyme Corporation
    • Novartis International AG
    • Roche Holding AG
    • Pfizer Inc.
    • Johnson &Johnson
    • AbbVie Inc.
    • Merck &Co., Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Takeda Pharmaceutical Company Limited
    • Alexion Pharmaceuticals, Inc.
    • Amgen Inc.
    • Vertex Pharmaceuticals Incorporated
    • Ionis Pharmaceuticals, Inc.
    • Sarepta Therapeutics, Inc.

第12章 分析師的全方位展望

Product Code: ANV1476

REPORT HIGHLIGHT

Rare Neurological Disease Treatment Market size was valued at USD 9,435.3 Million in 2022, expanding at a CAGR of 7.7% from 2023 to 2030.

The treatment of rare neurological diseases varies depending on the specific condition and its underlying cause. Thus, it becomes essential to consult with a healthcare professional or specialist for treatment of these neurological diseases.

Rare Neurological Disease Treatment Market- Market Dynamics:

Increasing research and development activities is expected to propel the rare neurological disease treatment demand.

Collaboration among researchers, medical professionals, pharmaceutical firms, and patient advocacy organizations has been essential in promoting the creation of medicines for uncommon neurological illnesses. Patient advocacy groups promote research, help, and create awareness, which improves patient outcomes and treatment alternatives. Technology advancements like next-generation sequencing, high-throughput screening, and gene editing methods have sped up the search for and development of viable treatments for uncommon neurological illnesses. Researchers may now identify therapeutic targets, create brand-new medications, and personalize therapy strategies thanks to these technologies.

The biological genetic and molecular developments involved in uncommon neurological illnesses are now better understood because of developments in genomics and molecular biology. This information has created new possibilities for precision medicine and targeted therapeutics.

Rare Neurological Disease Treatment Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Rare Neurological Disease Treatment market is estimated to grow annually at a CAGR of around 7.7% over the forecast period (2023-2030)
  • The Rare Neurological Disease Treatment industry is projected to grow at a significant rate due to the growing focus on animal health and nutrition.
  • Based on Disease Type, Alzheimer's disease segment was predicted to show maximum market share in the year 2022.
  • Based on Application, hospital pharmacies segment is expected to hold significant market share by 2030.
  • Based on Drug Class segmentation, anti-depressants segment was the leading in 2022
  • On the basis of region, North America was the leading revenue generator in 2022.

Rare Neurological Disease Treatment Market- Segmentation Analysis:

The Global Rare Neurological Disease Treatment Market is segmented on the basis of Drug Class, Disease Type, Application, and Region.

The market is divided into five categories based on Drug Class: Anti-depressants, anti-psychotics, cholinesterase inhibitors, biologics, and others. The Anti-depressants segment dominates the market. Growing demand for anti-depressants for disease care is contributing to market growth.

The market is divided into four categories based on Disease Type: Alzheimer's disease, narcolepsy, sclerosis, and others. The Alzheimer's disease segment dominates the market. Growing prevalence of Alzheimer disorders which is influencing the market growth.

The market is divided into three categories based on Application: hospitals & clinics, surgical centers, and others. The hospitals pharmacies segment dominates the market. The rising number of neurological disease treatment at hospital level is increasing the segment growth.

Rare Neurological Disease Treatment Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Rare Neurological Disease Treatment Market- Competitive Landscape:

Owing to the rising prevalence of neurological disorders, which influence the rare neurological disease treatment market. Several distribution channels, including corporate websites, and Disease Types, are used by businesses to sell their solutions & products. Products compete on various factors, such as technology, product creation, and marketing. reputation, and availability. Some of the primary techniques, and strategies used by corporations to consolidate their reach and grow their market share include new product launches, R&D expenditure, developing its distribution network and mergers & acquisitions. Some of the recent developments are mentioned below.

Recent Developments:

In 2021, Biogen developed Spinraza (nusinersen), an antisense oligonucleotide, for the treatment of small molecular therapies.

Key features of the study:

  • This proposed research study on Rare Neurological Disease Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Rare Neurological Disease Treatment market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Rare Neurological Disease Treatment market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Rare Neurological Disease Treatment market
  • Impact of COVID-19 on Rare Neurological Disease Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Rare Neurological Disease Treatment market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Rare Neurological Disease Treatment market, we have also included competitive landscape and key innovator analysis for the Rare Neurological Disease Treatment market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial in Drug Class and strategic initiatives of players operating in the Rare Neurological Disease Treatment market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Rare Neurological Disease Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET KEY PLAYERS

  • Biogen Inc.
  • Genzyme Corporation
  • Novartis International AG
  • Roche Holding AG
  • Pfizer Inc.
  • Johnson & Johnson
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Alexion Pharmaceuticals, Inc.
  • Amgen Inc.
  • Vertex Pharmaceuticals Incorporated
  • Ionis Pharmaceuticals, Inc.
  • Sarepta Therapeutics, Inc.

GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET, BY DRUG CLASS

  • Anti-depressants
  • Anti-psychotics
  • Cholinesterase inhibitors
  • Biologics
  • Others

GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET, BY DISEASE TYPE

  • Alzheimer's disease
  • Narcolepsy
  • Sclerosis
  • Others

GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET, BY APPLICATION

  • Hospitals & clinics
  • Surgical centers
  • Others

GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Rare Neurological Disease Treatment Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Rare Neurological Disease Treatment Market Snippet by Drug Class
    • 2.1.2. Rare Neurological Disease Treatment Market Snippet by Disease Type
    • 2.1.3. Rare Neurological Disease Treatment Market Snippet by Application
    • 2.1.4. Rare Neurological Disease Treatment Market Snippet by Country
    • 2.1.5. Rare Neurological Disease Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Rare Neurological Disease Treatment Key Market Trends

  • 3.1. Rare Neurological Disease Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Rare Neurological Disease Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Rare Neurological Disease Treatment Market Opportunities
  • 3.4. Rare Neurological Disease Treatment Market Future Trends

4. Rare Neurological Disease Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Rare Neurological Disease Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Rare Neurological Disease Treatment Market Landscape

  • 6.1. Rare Neurological Disease Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Rare Neurological Disease Treatment Market - By Drug Class

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Class, 2022 & 2030 (%)
    • 7.1.2. Anti-depressants
    • 7.1.3. Anti-psychotics
    • 7.1.4. Cholinesterase inhibitors
    • 7.1.5. Biologics
    • 7.1.6. Others

8. Rare Neurological Disease Treatment Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
    • 8.1.2. Alzheimer's disease
    • 8.1.3. Narcolepsy
    • 8.1.4. Sclerosis
    • 8.1.5. Others

9. Rare Neurological Disease Treatment Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
    • 9.1.2. Hospital & clinics
    • 9.1.3. Surgical centers
    • 9.1.4. Others

10. Rare Neurological Disease Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Rare Neurological Disease Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Rare Neurological Disease Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Rare Neurological Disease Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Rare Neurological Disease Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Rare Neurological Disease Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Rare Neurological Disease Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Biogen Inc.
    • 11.2.2. Genzyme Corporation
    • 11.2.3. Novartis International AG
    • 11.2.4. Roche Holding AG
    • 11.2.5. Pfizer Inc.
    • 11.2.6. Johnson & Johnson
    • 11.2.7. AbbVie Inc.
    • 11.2.8. Merck & Co., Inc.
    • 11.2.9. Teva Pharmaceutical Industries Ltd.
    • 11.2.10. Takeda Pharmaceutical Company Limited
    • 11.2.11. Alexion Pharmaceuticals, Inc.
    • 11.2.12. Amgen Inc.
    • 11.2.13. Vertex Pharmaceuticals Incorporated
    • 11.2.14. Ionis Pharmaceuticals, Inc.
    • 11.2.15. Sarepta Therapeutics, Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Rare Neurological Disease Treatment Market: Drug Class Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Rare Neurological Disease Treatment Market, by Drug Class 2018-2030 (USD Million)
  • TABLE Rare Neurological Disease Treatment Market: Disease Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global Rare Neurological Disease Treatment Market, by Disease Type 2018-2030 (USD Million)
  • TABLE Rare Neurological Disease Treatment Market: Regional snapshot (2022)
  • TABLE Rare Neurological Disease Treatment Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Rare Neurological Disease Treatment Market, by Application 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Rare Neurological Disease Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE North America Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE North America Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Europe Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Europe Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Asia Pacific Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Latin America Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Latin America Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)